Medical Condition News

RSS

Study provides new understanding of how the brain recovers from damage caused by stroke

Each year, approximately 265,000 Americans have a stroke that causes visual impairment. New research, which appears in the journal Proceedings of the Royal Society B, sheds light on how the damage in the brain caused by a stroke can lead to permanent vision impairment.

21 Mar 2019

New algae-based treatment could reduce need for limb amputation

A new algae-based treatment could reduce the need for amputation in people with critical limb ischaemia, according to new research funded by the British Heart Foundation, published today in the journal npj Regenerative Medicine.

21 Mar 2019

ADHD drug raising risk of psychosis

A new study has found that teenagers and youngsters who are treated with amphetamines such as Adderall are at a greater risk of developing psychosis compared to patients who are on other drugs such as Ritalin. The results of the study were published in the latest issue of the New England Journal of Medicine.

21 Mar 2019

Chemistry researchers patent new method for making anti-leukemia compounds

Chemistry researchers at Oregon State University have patented a method for making anti-leukemia compounds that until now have only been available via an Asian tree that produces them.

21 Mar 2019

New drugs on PBS for Parkinson's, MND and Cutaneous T cell lymphoma

Under Australia's Pharmaceutical Benefits Scheme (PBS), soon many of the rare diseases and their treatments are set to become cheaper.

21 Mar 2019

Stroke risk reduces in both black and white older Medicare beneficiaries, study reports

Recent reductions in hospitalization and death due to stroke extend to both black and white Medicare beneficiaries, reports a study in the April issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

21 Mar 2019

New Australian drug trial achieves remarkable results in patients with acute myeloid leukemia

The prognosis for older patients with acute myeloid leukemia is poor: very few achieve remission and for those that don't the option is largely palliative.

21 Mar 2019

MIT announces creation of the Alana Down Syndrome Center

As part of MIT's continued mission to help build a better world, the Institute announced the creation of the Alana Down Syndrome Center, an innovative new research endeavor, technology development initiative, and fellowship program launched with a $28.6 million gift from Alana Foundation, a nonprofit organization started by Ana Lucia Villela of São Paulo, Brazil.

21 Mar 2019

Researchers discover possible new therapeutic strategy for pancreatic cancer

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a possible new therapeutic strategy using two types of drug inhibitors at once to treat one of the world's deadliest cancers.

21 Mar 2019

FDA approves brexanolone, first drug developed to treat postpartum depression

Approximately 1 in 9 women in the United States experiences symptoms of postpartum depression, according to the Centers for Disease Control and Prevention.

21 Mar 2019

Study finds link between depression in 20s linked to memory loss in 50s

A new large-scale longitudinal study carried out by University of Sussex psychologists has found a clear link between episodes of depression and anxiety experienced by adults in their twenties, thirties and forties, with a decrease in memory function by the time they are in their fifties.

21 Mar 2019

Positive link found between anxiety during childhood, adolescence with later alcohol use disorders

In an Addiction analysis of relevant published studies, investigators found some evidence for a positive association between anxiety during childhood and adolescence with later alcohol use disorders.

20 Mar 2019

First postpartum depression drug gets FDA nod

Sage therapeutics’ Zulresso became the first drug approved for postpartum depression by the United States Food and Drugs Administration (FDA). This cause the shares of Sage to rise by over 5 percent on Tuesday this week.

20 Mar 2019

High potency cannabis use linked to psychosis finds study

With more and more states and regions legalizing the use of medical marijuana or cannabis, experts are also looking at the long term effects of marijuana use and its safety. According to a new study published this week in the journal The Lancet Psychiatry, frequent use of marijuana can lead to psychotic episodes.

20 Mar 2019

Overall rates of death from breast cancer are falling across the EU

Researchers at the University of Milan have predicted that death rates from breast cancer will fall this year in all European Union (EU) countries, with the exception of Poland.

20 Mar 2019

Study explores whether alcohol consumption can have an effect on arthritis

Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.

20 Mar 2019

Most pills contain common allergens, warn experts

Pills or oral medications contain inactive ingredients such as gluten that may be responsible for dangerous side effects, concludes a new study.

20 Mar 2019

Mental health problems in young adults on the rise

A new study has revealed that mental health problems among young adults and adolescents are on the rise.

20 Mar 2019

Active substance from plant could turn into a ray of hope against eye tumors

An active substance that has been known for 30 years could unexpectedly turn into a ray of hope against eye tumors.

20 Mar 2019

Review: Majority of osteoporosis clinical practice guidelines ignore patients' voices

Patients' voices are ignored all too often in osteoporosis clinical practice guidelines, say researchers, who reviewed 70 English-language guidelines around the world and found less than 40 percent included any mention of patients' beliefs, values or preferences.

20 Mar 2019